Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
CA24463V1013
Mon, 19.08.2024
Defence Therapeutics Inc.
_________________________________________________________________
CSE: DTC FSE: DTC USOTC: DTCFF PRESS RELEASE
DEFENCE INVESTIGATES THE APPLICATION OF THE ACCUM® HYDROGEL TECHNOLOGY TO DELIVER GLP-1 IN ORDER TO INCREASE THE TREATMENT EFFICACY OF DIABETES AND WEIGHT LOSS
Vancouver, BC, Canada, August 19th, 2024 - Defence Therapeutics I [ … ]
Tue, 13.08.2024
Defence Therapeutics Inc.
_________________________________________________________________
CSE: DTC FSE: DTC USOTC: DTCFF PRESS RELEASE
DEFENCE THERAPEUTICS COLLABORATION AGREEMENT WITH ORANO TO DEVELOP THE NEXT GENERATION OF TARGETED RADIO-IMMUNOTHERAPY FOR CANCER ADVANCES
Vancouver, BC, Canada, August 13th, 2024 - Defence Therapeutics Inc. (“Defence” or [ … ]
Wed, 24.07.2024
Defence Therapeutics Inc.
_________________________________________________________________
CSE: DTC FSE: DTC USOTC: DTCFF PRESS RELEASE
DEFENCE THERAPEUTICS GRANTED CNRI-H FROM THE CANADIAN NUCLEAR LABORATORIES TO ACCELERATE THE DEVELOPMENT OF ITS RADIO-IMMUNO-CONJUGATES PROGRAM
Vancouver, BC, Canada, July 24th, 2024 - Defence Therapeutics Inc. (“Defence” o [ … ]
Mon, 08.07.2024
Defence Therapeutics Inc.
_________________________________________________________________
CSE: DTC FSE: DTC USOTC: DTCFF PRESS RELEASE
DEFENCE RECEIVES NO OBJECTION LETTER FROM HEALTH CANADA FOR PHASE I TRIAL OF ITS ACCUM-002 (ACCUTOX) AS AN ANTI-CANCER MOLECULE IN PATIENTS WITH MELANOMA
Vancouver, BC, Canada, July 8th, 2024 - Defence Therapeutics Inc. (“ [ … ]
Mon, 01.07.2024
Defence Therapeutics Inc.
_________________________________________________________________
CSE: DTC FSE: DTC USOTC: DTCFF PRESS RELEASE
DEFENCE’S ACCUTOX BOOSTS AND SYNERGIZES WITH IMMUNE CHECKPOINT INHIBITORS
Vancouver, BC, Canada, June 28th, 2024 - Defence Therapeutics Inc. (“Defence” or the “Company”), (CSE: DTC, OTCQB: DTCFF, FSE: DTC), a Canadian biop [ … ]
Tue, 25.06.2024
Defence Therapeutics Inc.
CSE: DTC FSE: DTC USOTC: DTCFF PRESS RELEASE
Vancouver, BC, Canada, June 25th, 2024 - Defence Therapeutics Inc. (“Defence” or the “Company”), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is pleased to announce that its second-generation ARM-X anti-cancer vaccine is therap [ … ]
Tue, 25.06.2024
Defence Therapeutics Inc.
CSE: DTC FSE: DTC USOTC: DTCFF PRESS RELEASE
Vancouver, BC, Canada, June 25th, 2024 - Defence Therapeutics Inc. (“Defence” or the “Company”), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is pleased to announce that its second-generation ARM-X anti-cancer vaccine is therap [ … ]
Mon, 17.06.2024
Defence Therapeutics Inc.
_________________________________________________________________
CSE: DTC FSE: DTC USOTC: DTCFF PRESS RELEASE
DEFENCE’S CHIEF SCIENTIFIC OFFICER DR. MOUTIH RAFEI DISCUSSES THE ACCUM PLATFORM FOR CANCER TREATMENTS ON MONEY TALK RADIO WITH ELLIS MARTIN
Vancouver, BC, Canada, June 17th, 2024 - Defence Therapeutics Inc. (“Defence” or [ … ]
Mon, 10.06.2024
Defence Therapeutics Inc.
_________________________________________________________________
CSE: DTC FSE: DTC USOTC: DTCFF PRESS RELEASE
DEFENCE TO PARTICIPATE TO 2024 SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING ANNUAL MEETING IN TORONTO ON JUNE 11, 2024
Vancouver, BC, Canada, June 10th, 2024 - Defence Therapeutics Inc. (“Defence” or the “Company”), ( [ … ]
Thu, 06.06.2024
Defence Therapeutics Inc.
_________________________________________________________________
CSE: DTC FSE: DTC USOTC: DTCFF PRESS RELEASE
DEFENCE’S ACCUTOX PUBLISHED IN THE PRESTIGIOUS JOURNAL OF TRANSLATIONAL MEDICINE ITS PEER STUDY WITH PRECLINICAL DATA ON ACCUTOX AS AN ANTI-CANCER MOLECULE
Vancouver, BC, Canada, June 6th, 2024 - Defence Therapeutics Inc. ( [ … ]